APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antacid

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.

Selected research

Industry Growth & Trends

Global Antacid Industry Growth and Trends Forecast to 2032

Report ID 173964400121 December 2025107 pages

Choose your research edition.

Industry ResearchAntacid Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Antacid Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antacid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antacid Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Antacid Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.

Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.

Read the full market overview

In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.

Report Scope

This report provides a structured, data-driven view of the global Antacid market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antacid market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antacid market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antacid.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antacid market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antacid Market by Company

AstraZeneca

Takeda Pharmaceutical

Pfizer

Reckitt Benckiser

Bayer

Procter＆Gamble

GlaxoSmithKline

Johnson＆Johnson

CONBA

Xiuzheng Pharma

Sanofi

Bausch Health

CR SANJIU

Reddy's Laboratories

Antacid Segment by Type

Proton Pump Inhibitor

H2 Antagonist

Acid Neutralizers

Antacid Segment by Application

OTC Drug

Rx Drug

Antacid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antacid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antacid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antacid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antacid manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antacid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Proton Pump Inhibitor Table 2. Major Company of H2 Antagonist Table 3. Major Company of Acid Neutralizers Table 4. Global Antacid Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antacid Sales by Type (2021-2026) & (M Units) Table 6. Global Antacid Sales Market Share in Volume by Type (2021-2026) Table 7. Global Antacid Sales by Type (2021-2026) & (US$ Million) Table 8. Global Antacid Sales Market Share in Value by Type (2021-2026) Table 9. Global Antacid Price by Type (2021-2026) & (USD/Unit) Table 10. Global Antacid Sales by Type (2027-2032) & (M Units) Table 11. Global Antacid Sales Market Share in Volume by Type (2027-2032) Table 12. Global Antacid Sales by Type (2027-2032) & (US$ Million) Table 13. Global Antacid Sales Market Share in Value by Type (2027-2032) Table 14. Global Antacid Price by Type (2027-2032) & (USD/Unit) Table 15. North America Antacid Sales by Type (2021-2026) & (M Units) Table 16. North America Antacid Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Antacid Sales by Type (2021-2026) & (M Units) Table 18. Europe Antacid Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Antacid Sales by Type (2021-2026) & (M Units) Table 20. Asia-Pacific Antacid Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Antacid Sales by Type (2021-2026) & (M Units) Table 22. Latin America Antacid Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Antacid Sales by Type (2021-2026) & (M Units) Table 24. Middle East and Africa Antacid Sales by Type (2021-2026) & (US$ Million) Table 25. Antacid Industry Trends Table 26. Antacid Industry Drivers Table 27. Antacid Industry Opportunities and Challenges Table 28. Antacid Industry Restraints Table 29. Global Antacid Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Antacid Revenue Market Share by Company (2021-2026) Table 31. Global Antacid Sales by Company (2021-2026) & (M Units) Table 32. Global Antacid Sales Share by Company (2021-2026) Table 33. Global Antacid Market Price by Company (2021-2026) & (USD/Unit) Table 34. Global Antacid Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antacid Major Company Production Sites and Headquarters Table 36. Global Antacid Company, Product Type & Application Table 37. Global Antacid Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Antacid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antacid Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Antacid Sales by Region (2021-2026) & (M Units) Table 42. Global Antacid Sales Market Share in Volume by Region (2021-2026) Table 43. Global Antacid Sales by Region (2021-2026) & (US$ Million) Table 44. Global Antacid Sales Market Share in Value by Region (2021-2026) Table 45. Global Antacid Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Global Antacid Sales by Region (2027-2032) & (M Units) Table 47. Global Antacid Sales Market Share in Volume by Region (2027-2032) Table 48. Global Antacid Sales by Region (2027-2032) & (US$ Million) Table 49. Global Antacid Sales Market Share in Value by Region (2027-2032) Table 50. Global Antacid Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 51. Global Antacid Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Antacid Sales by Application (2021-2026) & (M Units) Table 53. Global Antacid Sales Market Share in Volume by Application (2021-2026) Table 54. Global Antacid Sales by Application (2021-2026) & (US$ Million) Table 55. Global Antacid Sales Market Share in Value by Application (2021-2026) Table 56. Global Antacid Price by Application (2021-2026) & (USD/Unit) Table 57. Global Antacid Sales by Application (2027-2032) & (M Units) Table 58. Global Antacid Sales Market Share in Volume by Application (2027-2032) Table 59. Global Antacid Sales by Application (2027-2032) & (US$ Million) Table 60. Global Antacid Sales Market Share in Value by Application (2027-2032) Table 61. Global Antacid Price by Application (2027-2032) & (USD/Unit) Table 62. North America Antacid Sales by Application (2021-2026) & (M Units) Table 63. North America Antacid Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Antacid Sales by Application (2021-2026) & (M Units) Table 65. Europe Antacid Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Antacid Sales by Application (2021-2026) & (M Units) Table 67. Asia-Pacific Antacid Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Antacid Sales by Application (2021-2026) & (M Units) Table 69. Latin America Antacid Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Antacid Sales by Application (2021-2026) & (M Units) Table 71. Middle East and Africa Antacid Sales by Application (2021-2026) & (US$ Million) Table 72. AstraZeneca Company Information Table 73. AstraZeneca Business Overview Table 74. AstraZeneca Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. AstraZeneca Antacid Product Portfolio Table 76. AstraZeneca Recent Development Table 77. Takeda Pharmaceutical Company Information Table 78. Takeda Pharmaceutical Business Overview Table 79. Takeda Pharmaceutical Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Takeda Pharmaceutical Antacid Product Portfolio Table 81. Takeda Pharmaceutical Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Pfizer Antacid Product Portfolio Table 86. Pfizer Recent Development Table 87. Reckitt Benckiser Company Information Table 88. Reckitt Benckiser Business Overview Table 89. Reckitt Benckiser Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Reckitt Benckiser Antacid Product Portfolio Table 91. Reckitt Benckiser Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Bayer Antacid Product Portfolio Table 96. Bayer Recent Development Table 97. Procter＆Gamble Company Information Table 98. Procter＆Gamble Business Overview Table 99. Procter＆Gamble Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Procter＆Gamble Antacid Product Portfolio Table 101. Procter＆Gamble Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Antacid Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. Johnson＆Johnson Company Information Table 108. Johnson＆Johnson Business Overview Table 109. Johnson＆Johnson Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Johnson＆Johnson Antacid Product Portfolio Table 111. Johnson＆Johnson Recent Development Table 112. CONBA Company Information Table 113. CONBA Business Overview Table 114. CONBA Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. CONBA Antacid Product Portfolio Table 116. CONBA Recent Development Table 117. Xiuzheng Pharma Company Information Table 118. Xiuzheng Pharma Business Overview Table 119. Xiuzheng Pharma Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. Xiuzheng Pharma Antacid Product Portfolio Table 121. Xiuzheng Pharma Recent Development Table 122. Sanofi Company Information Table 123. Sanofi Business Overview Table 124. Sanofi Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 125. Sanofi Antacid Product Portfolio Table 126. Sanofi Recent Development Table 127. Bausch Health Company Information Table 128. Bausch Health Business Overview Table 129. Bausch Health Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 130. Bausch Health Antacid Product Portfolio Table 131. Bausch Health Recent Development Table 132. CR SANJIU Company Information Table 133. CR SANJIU Business Overview Table 134. CR SANJIU Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 135. CR SANJIU Antacid Product Portfolio Table 136. CR SANJIU Recent Development Table 137. Reddy's Laboratories Company Information Table 138. Reddy's Laboratories Business Overview Table 139. Reddy's Laboratories Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 140. Reddy's Laboratories Antacid Product Portfolio Table 141. Reddy's Laboratories Recent Development Table 142. North America Antacid Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 143. North America Antacid Sales by Country (2021-2026) & (M Units) Table 144. North America Antacid Sales Market Share by Country (2021-2026) Table 145. North America Antacid Sales Forecast by Country (2027-2032) & (M Units) Table 146. North America Antacid Sales Market Share Forecast by Country (2027-2032) Table 147. North America Antacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Antacid Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Antacid Market Share by Country (2021-2026) Table 150. North America Antacid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Antacid Market Share Forecast by Country (2027-2032) Table 152. Europe Antacid Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 153. Europe Antacid Sales by Country (2021-2026) & (M Units) Table 154. Europe Antacid Sales Market Share by Country (2021-2026) Table 155. Europe Antacid Sales Forecast by Country (2027-2032) & (M Units) Table 156. Europe Antacid Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Antacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Antacid Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Antacid Market Share by Country (2021-2026) Table 160. Europe Antacid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Antacid Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Antacid Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Antacid Sales by Country (2021-2026) & (M Units) Table 164. Asia-Pacific Antacid Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Antacid Sales Forecast by Country (2027-2032) & (M Units) Table 166. Asia-Pacific Antacid Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Antacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Antacid Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Antacid Market Share by Country (2021-2026) Table 170. Asia-Pacific Antacid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Antacid Market Share Forecast by Country (2027-2032) Table 172. Latin America Antacid Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 173. Latin America Antacid Sales by Country (2021-2026) & (M Units) Table 174. Latin America Antacid Sales Market Share by Country (2021-2026) Table 175. Latin America Antacid Sales Forecast by Country (2027-2032) & (M Units) Table 176. Latin America Antacid Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Antacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Antacid Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Antacid Market Share by Country (2021-2026) Table 180. Latin America Antacid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Antacid Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Antacid Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Antacid Sales by Country (2021-2026) & (M Units) Table 184. Middle East and Africa Antacid Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Antacid Sales Forecast by Country (2027-2032) & (M Units) Table 186. Middle East and Africa Antacid Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Antacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Antacid Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Antacid Market Share by Country (2021-2026) Table 190. Middle East and Africa Antacid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Antacid Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Antacid Distributors List Table 195. Antacid Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Antacid Image Figure 2. Global Antacid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antacid Market Size (2021-2032) & (US$ Million) Figure 4. Global Antacid Sales (2021-2032) & (M Units) Figure 5. Proton Pump Inhibitor Image Figure 6. Global Proton Pump Inhibitor Sales YoY Growth (2021-2032) & (M Units) Figure 7. H2 Antagonist Image Figure 8. Global H2 Antagonist Sales YoY Growth (2021-2032) & (M Units) Figure 9. Acid Neutralizers Image Figure 10. Global Acid Neutralizers Sales YoY Growth (2021-2032) & (M Units) Figure 11. Global Antacid Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Antacid Market Share by Type 2025 VS 2032 Figure 13. North America Antacid Sales Market Share in Volume by Type in 2025 Figure 14. North America Antacid Sales Market Share in Value by Type in 2025 Figure 15. Europe Antacid Sales Market Share in Volume by Type in 2025 Figure 16. Europe Antacid Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Antacid Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Antacid Sales Market Share in Value by Type in 2025 Figure 19. Latin America Antacid Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Antacid Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Antacid Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Antacid Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Antacid Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. OTC Drug Image Figure 26. Global OTC Drug Sales YoY Growth (2021-2032) & (M Units) Figure 27. Rx Drug Image Figure 28. Global Rx Drug Sales YoY Growth (2021-2032) & (M Units) Figure 29. Global Antacid Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Antacid Market Share by Application 2025 VS 2032 Figure 31. North America Antacid Sales Market Share in Volume by Application in 2025 Figure 32. North America Antacid Sales Market Share in Value by Application in 2025 Figure 33. Europe Antacid Sales Market Share in Volume by Application in 2025 Figure 34. Europe Antacid Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Antacid Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Antacid Sales Market Share in Value by Application in 2025 Figure 37. Latin America Antacid Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Antacid Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Antacid Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Antacid Sales Market Share in Value by Application in 2025 Figure 41. North America Antacid Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 42. North America Antacid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Antacid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Antacid Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Antacid Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. Europe Antacid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antacid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Antacid Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Antacid Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Asia-Pacific Antacid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antacid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Antacid Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Antacid Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Latin America Antacid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antacid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Antacid Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Antacid Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Middle East and Africa Antacid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antacid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Antacid Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Antacid Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Antacid Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Proton Pump Inhibitor
  • H2 Antagonist
  • Acid Neutralizers
Applications
  • OTC Drug
  • Rx Drug
Companies covered
  • AstraZeneca
  • Takeda Pharmaceutical
  • Pfizer
  • Reckitt Benckiser
  • Bayer
  • Procter＆Gamble
  • GlaxoSmithKline
  • Johnson＆Johnson
  • CONBA
  • Xiuzheng Pharma
  • Sanofi
  • Bausch Health
  • CR SANJIU
  • Reddy's Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antacid Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antacid Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antacid Market by Type
  6. 1.3.1 Proton Pump Inhibitor
  7. 1.3.2 H2 Antagonist
  8. 1.3.3 Acid Neutralizers
  9. 1.4 Global Antacid Market Size by Type
  10. 1.4.1 Global Antacid Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Antacid Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Antacid Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Antacid Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Antacid Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Antacid Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Antacid Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Antacid Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antacid Industry Trends
  2. 2.2 Antacid Industry Drivers
  3. 2.3 Antacid Industry Opportunities and Challenges
  4. 2.4 Antacid Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antacid Revenue (2021-2026)
  2. 3.2 Global Top Players by Antacid Sales (2021-2026)
  3. 3.3 Global Top Players by Antacid Price (2021-2026)
  4. 3.4 Global Antacid Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antacid Major Company Production Sites & Headquarters
  6. 3.6 Global Antacid Company, Product Type & Application
  7. 3.7 Global Antacid Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antacid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antacid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antacid Tier 1, Tier 2, and Tier 3
4 Antacid Regional Status and Outlook
  1. 4.1 Global Antacid Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antacid Historic Market Size by Region
  3. 4.2.1 Global Antacid Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antacid Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antacid Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antacid Forecasted Market Size by Region
  7. 4.3.1 Global Antacid Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antacid Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antacid Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antacid by Application
  1. 5.1 Antacid Market by Application
  2. 5.1.1 OTC Drug
  3. 5.1.2 Rx Drug
  4. 5.2 Global Antacid Market Size by Application
  5. 5.2.1 Global Antacid Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Antacid Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Antacid Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Antacid Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Antacid Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Antacid Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Antacid Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Antacid Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Antacid Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Antacid Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Takeda Pharmaceutical
  8. 6.2.1 Takeda Pharmaceutical Company Information
  9. 6.2.2 Takeda Pharmaceutical Business Overview
  10. 6.2.3 Takeda Pharmaceutical Antacid Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Pharmaceutical Antacid Product Portfolio
  12. 6.2.5 Takeda Pharmaceutical Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Antacid Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Antacid Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Reckitt Benckiser
  20. 6.4.1 Reckitt Benckiser Company Information
  21. 6.4.2 Reckitt Benckiser Business Overview
  22. 6.4.3 Reckitt Benckiser Antacid Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Reckitt Benckiser Antacid Product Portfolio
  24. 6.4.5 Reckitt Benckiser Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Antacid Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer Antacid Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Procter＆Gamble
  32. 6.6.1 Procter＆Gamble Company Information
  33. 6.6.2 Procter＆Gamble Business Overview
  34. 6.6.3 Procter＆Gamble Antacid Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Procter＆Gamble Antacid Product Portfolio
  36. 6.6.5 Procter＆Gamble Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Antacid Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Antacid Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Johnson＆Johnson
  44. 6.8.1 Johnson＆Johnson Company Information
  45. 6.8.2 Johnson＆Johnson Business Overview
  46. 6.8.3 Johnson＆Johnson Antacid Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Johnson＆Johnson Antacid Product Portfolio
  48. 6.8.5 Johnson＆Johnson Recent Developments
  49. 6.9 CONBA
  50. 6.9.1 CONBA Company Information
  51. 6.9.2 CONBA Business Overview
  52. 6.9.3 CONBA Antacid Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CONBA Antacid Product Portfolio
  54. 6.9.5 CONBA Recent Developments
  55. 6.10 Xiuzheng Pharma
  56. 6.10.1 Xiuzheng Pharma Company Information
  57. 6.10.2 Xiuzheng Pharma Business Overview
  58. 6.10.3 Xiuzheng Pharma Antacid Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Xiuzheng Pharma Antacid Product Portfolio
  60. 6.10.5 Xiuzheng Pharma Recent Developments
  61. 6.11 Sanofi
  62. 6.11.1 Sanofi Company Information
  63. 6.11.2 Sanofi Business Overview
  64. 6.11.3 Sanofi Antacid Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sanofi Antacid Product Portfolio
  66. 6.11.5 Sanofi Recent Developments
  67. 6.12 Bausch Health
  68. 6.12.1 Bausch Health Company Information
  69. 6.12.2 Bausch Health Business Overview
  70. 6.12.3 Bausch Health Antacid Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bausch Health Antacid Product Portfolio
  72. 6.12.5 Bausch Health Recent Developments
  73. 6.13 CR SANJIU
  74. 6.13.1 CR SANJIU Company Information
  75. 6.13.2 CR SANJIU Business Overview
  76. 6.13.3 CR SANJIU Antacid Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 CR SANJIU Antacid Product Portfolio
  78. 6.13.5 CR SANJIU Recent Developments
  79. 6.14 Reddy's Laboratories
  80. 6.14.1 Reddy's Laboratories Company Information
  81. 6.14.2 Reddy's Laboratories Business Overview
  82. 6.14.3 Reddy's Laboratories Antacid Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Reddy's Laboratories Antacid Product Portfolio
  84. 6.14.5 Reddy's Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Antacid Sales by Country
  2. 7.1.1 North America Antacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antacid Sales by Country (2021-2026)
  4. 7.1.3 North America Antacid Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antacid Market Size by Country
  6. 7.2.1 North America Antacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antacid Market Size by Country (2021-2026)
  8. 7.2.3 North America Antacid Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antacid Sales by Country
  2. 8.1.1 Europe Antacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antacid Sales by Country (2021-2026)
  4. 8.1.3 Europe Antacid Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antacid Market Size by Country
  6. 8.2.1 Europe Antacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antacid Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antacid Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antacid Sales by Country
  2. 9.1.1 Asia-Pacific Antacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antacid Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antacid Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antacid Market Size by Country
  6. 9.2.1 Asia-Pacific Antacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antacid Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antacid Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antacid Sales by Country
  2. 10.1.1 South America Antacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antacid Sales by Country (2021-2026)
  4. 10.1.3 South America Antacid Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antacid Market Size by Country
  6. 10.2.1 South America Antacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antacid Market Size by Country (2021-2026)
  8. 10.2.3 South America Antacid Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antacid Sales by Country
  2. 11.1.1 Middle East and Africa Antacid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antacid Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antacid Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antacid Market Size by Country
  6. 11.2.1 Middle East and Africa Antacid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antacid Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antacid Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antacid Value Chain Analysis
  2. 12.1.1 Antacid Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antacid Production Mode & Process
  7. 12.2 Antacid Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antacid Distributors
  10. 12.2.3 Antacid Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst